Skip to main content

Advertisement

Table 1 General characteristics of chronic central serous chorioretinopathy patients who were good and poor responders to photodynamic therapy

From: The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study

  Good responder group Poor responder group p value
Age 50.7 ± 10.1 years (range 34–82) 55.2 ± 13.3 years (range 26–73) 0.08*
Gender (M/F) 59/17 21/4 0.4
Mean duration of the disease 17.5 ± 12.7 months (range 7–80 months) 15.7 ± 8.4 months (range 7–41 months) 0.5*
Mean baseline BCVA 0.49 ± 0.28 decimals (range 0.01–1.0) 0.37 ± 0.25 decimals (range 0.03–1.0) 0.06*
Mean baseline FT 329 ± 79 microns (range 197–575 microns) 301 ± 57 microns (range 207–399 microns) 0.1*
  1. M/F male/female, BCVA best corrected visual acuity, FT foveal thickness
  2. * Independent-samples T test
  3. Chi square test